Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Pfizer Inc. (PFZ)
Share Price: $28.37 Change Today: $-0.59  Market Cap: $201,235m

Pfizer Inc. Overview

In 1849, Charles Pfizer & Company opened as a fine-chemicals business. Now, as a research-based, global pharmaceutical company, Pfizer is the world's largest company devoted to healthcare, with products available in more than 150 countries. In June 2000, Pfizer completed the acquisition of Warner-Lambert, creating the world's most valuable and fastest-growing pharmaceutical company, and, in April 2003, merged with Pharmacia Corporation, enlarging Pfizer's portfolio of consumer healthcare brands and expanding its animal health business.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Pfizer Inc. Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 48,296.00 9,694.00 242.00¢ 4.9 0.0 +105% 128.00¢ 10.8%
31-Dec-09 50,009.00 10,827.00 202.00¢ 9.1 n/a -16% 80.00¢ 4.3%
31-Dec-10 67,057.00 9,282.00 222.00¢ 7.8 0.8 +10% 72.00¢ 4.1%
31-Dec-11 65,259.00 12,304.00 107.00¢ 20.6 n/a -52% 80.00¢ 3.6%
31-Dec-12 58,986.00 12,080.00 127.00¢ 19.4 1.0 +19% 88.00¢ 3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Pfizer Inc. Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 56,663.41 21,819.11 222.83¢ 12.7 0.2 +76% 95.19¢ 3.3%
31-Dec-14 55,721.91 22,062.83 235.54¢ 12.0 2.1 +6% 102.50¢ 3.5%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

Pfizer Inc. Company Announcements

Partners Pfizer for over-the-counter Nexium 14-Aug-2012 07:00 RNS
Pfizer License Extension 04-May-2011 07:00 RNS
Election of Home Member State 24-Jul-2009 11:44 RNS

Latest Pfizer Inc. Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency US Dollars
Share Price $ 28.37
Change Today $ -0.59
% Change -2.04 %
Volume 9,797
21-May-13 Close $28.37
Shares Issued 7,093m
Market Cap $201,235m
Year End 31-Dec-12

What The Brokers Say

Strong Buy 12
Buy 4
Neutral 5
Sell 0
Strong Sell 0
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Pfizer Inc. Dividends

  Latest Previous
  Q1
Ex-Div n/a
Paid n/a
Amount 24.00¢

Trades for 21-May-2013

Time Volume / Share Price
15:54 225 @ $28.37
15:53 5,500 @ $28.33
15:50 212 @ $28.38
14:34 3,700 @ $28.79
14:33 160 @ $28.70


www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/www.digitallook.com